U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
120421120421Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected PatientsActive, not recruitingNo Results AvailableImmune Reconstitution Inflammatory Syndrome|HIV|HIV InfectionsDrug: maraviroc|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00988780
120422120422Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis BCompletedNo Results AvailableChronic Hepatitis BBiological: DNA vaccinehttps://ClinicalTrials.gov/show/NCT00988767
120423120423School Based Health Promotion Program in Secondary SchoolsCompletedNo Results AvailableObesity|Cardiovascular RiskBehavioral: School children and adolescents as health expertshttps://ClinicalTrials.gov/show/NCT00988754
120424120424Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic TherapyCompletedNo Results AvailableUnresectable Hepatocellular CarcinomaDrug: ARQ 197|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00988741
120425120425Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN)WithdrawnNo Results AvailableSchizophreniaDrug: SCH 900435 (Org 25935)|Drug: Placebo|Drug: Olanzapinehttps://ClinicalTrials.gov/show/NCT00988728
120426120426Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeActive, not recruitingNo Results AvailableChronic Myelomonocytic Leukemia|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Refractory Anemia With Excess BlastBiological: Pretargeted Radioimmunotherapy|Drug: Cyclosporine|Drug: Mycophenolate Mofetil|Radiation: Total-Body Irradiation|Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation|Procedure: Peripheral Blood Stem Cell Transplantation|Drug: Fludarabine Phosphate|Other: Pharmacological Study|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT00988715
120427120427Shaolin Dan Tian Breathing Fosters Relaxed and Attentive MindActive, not recruitingNo Results AvailableAttention|ElectroencephalographyBehavioral: Dan Tian Breathing|Behavioral: Progressive muscle traininghttps://ClinicalTrials.gov/show/NCT00988702
120428120428Types of Starch and Their Effect on Blood Glucose, Appetite and Food IntakeCompletedNo Results AvailableObesity Prevention|Diabetes PreventionOther: Dietary Interventionhttps://ClinicalTrials.gov/show/NCT00988689
120429120429The Effect of Bowel Preparation Status on the Polyp Missing RateCompletedNo Results AvailableColorectal Polyps|Colonoscopy|Bowel Preparation|Polyp Missing Ratehttps://ClinicalTrials.gov/show/NCT00988676
120430120430The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems?Not yet recruitingNo Results AvailableMajor Depressive DisorderDrug: memantine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00988663
120431120431Mediterranean Diet and the Metabolic SyndromeCompletedNo Results AvailableCardiovascular DiseaseOther: isocaloric diet|Other: free living conditionshttps://ClinicalTrials.gov/show/NCT00988650
120432120432Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque PsoriasisCompletedHas ResultsPlaque PsoriasisDrug: Vectical™ Ointment weekdays and Clobex® Spray weekends regimen|Drug: Clobex® Spray morning and Vectical™ Ointment evening regimenhttps://ClinicalTrials.gov/show/NCT00988637
120433120433A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)CompletedNo Results AvailableAlzheimer's Disease|Huntington DiseaseDrug: Dimebon IR Tablet|Drug: Dimebon MR1|Drug: Dimebon MR2|Drug: Dimebon MR3|Drug: Dimebon MR4https://ClinicalTrials.gov/show/NCT00988624
120434120434Assisted Reproductive Technology (ART) Predictors StudyEnrolling by invitationNo Results AvailableReproductive AgingOther: Women undergoing IVF/ART cycles at OU Physicians Reproductive Health Clinic in Oklahoma City, Oklahomahttps://ClinicalTrials.gov/show/NCT00988611
120435120435A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer's DiseaseDrug: PF-04447943|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00988598
120436120436Evaluation of the Safety and Biologic Effects of an Eicosapentaenoic (EPA)-Enriched OilCompletedNo Results AvailableHeart DiseaseDietary Supplement: EPA 600|Dietary Supplement: EPA 1800|Dietary Supplement: Olive Oil|Dietary Supplement: DHAhttps://ClinicalTrials.gov/show/NCT00988585
120437120437Vestibular Rehabilitation for Patients With Fall-related Wrist FracturesCompletedNo Results AvailableWrist Fractures|DizzinessOther: Vestibular rehabilitationhttps://ClinicalTrials.gov/show/NCT00988572
120438120438Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)RecruitingNo Results AvailableHPV16+|Cervical Intraepithelial Neoplasia (CIN 2/3)Biological: DNA vaccination|Device: Gene gun vaccine|Biological: intramuscular vaccination|Biological: intra-lesional vaccine administration|Procedure: therapeutic resection of the lesion|Drug: imiquimodhttps://ClinicalTrials.gov/show/NCT00988559
120439120439Evaluation of Computerized Template Entry for Compensation and Pension (C&P) ExaminationsCompletedNo Results AvailableJoint DiseasesOther: Computer based template for exam documentation|Other: Dictation for exam documentationhttps://ClinicalTrials.gov/show/NCT00988546
120440120440A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of AgeCompletedHas ResultsHead LiceDrug: 0.5% Ivermectin Creamhttps://ClinicalTrials.gov/show/NCT00988533
120441120441Study of Efficacy, Pharmacokinetics and Safety of Continuous Intravenous Infusion of Org 9426 (Study P05977)CompletedNo Results AvailableAnesthesiaDrug: Rocuronium bromide|Drug: Rocuronium bromide|Drug: Rocuronium bromide|Drug: Sevoflurane|Drug: Propofolhttps://ClinicalTrials.gov/show/NCT00988520
120442120442Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum MalariaTerminatedNo Results AvailablePlasmodium Falciparum InfectionDrug: Ferroquine (SSR97193)|Drug: Placebo|Drug: artesunatehttps://ClinicalTrials.gov/show/NCT00988507
120443120443Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial DefectCompletedNo Results AvailablePersistent Corneal Epithelial DefectDrug: DE-105 ophthalmic solution|Drug: DE-105 ophthalmic solution|Drug: Placebo ophthalmic solutionhttps://ClinicalTrials.gov/show/NCT00988494
120444120444Topiramate Augmentation in Bulimia Nervosa Partial RespondersWithdrawnNo Results AvailableBulimia NervosaDrug: Topiramatehttps://ClinicalTrials.gov/show/NCT00988481
120445120445Manual Therapy Versus Exercise on Knee OsteoarthritisTerminatedNo Results AvailableKnee OsteoarthritisProcedure: Manual Therapy|Behavioral: Therapeutic Exercise|Behavioral: Video Observationhttps://ClinicalTrials.gov/show/NCT00988468
120446120446Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-upCompletedNo Results AvailableBasal Cell CarcinomaRadiation: photodynamic therapyhttps://ClinicalTrials.gov/show/NCT00988455
120447120447Telephone Support to Improve Adherence to Anti-HIV MedicationsCompletedNo Results AvailableHIV InfectionsBehavioral: Enhanced nursing telephone support|Behavioral: Standard carehttps://ClinicalTrials.gov/show/NCT00988442
120448120448Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial SeizuresActive, not recruitingHas ResultsPartial EpilepsyDrug: 800 mg QD Eslicarbazepine acetate|Drug: 1200 mg QD Eslicarbazepine acetate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00988429
120449120449Positron Emission Tomography-computed Tomography (PET-CT) for Main & Branch Intraductal Papillary Mucinous NeoplasmRecruitingNo Results AvailableIntraductal Papillary Mucinous NeoplasmProcedure: PET-CThttps://ClinicalTrials.gov/show/NCT00988416
120450120450Investigation of Dietary Absorptive Capacity of Fructans in Healthy Subjects - A Dose Response StudyActive, not recruitingNo Results AvailableHealthy VolunteersDietary Supplement: Fructan - 7.5|Dietary Supplement: Fructan - 10|Dietary Supplement: Fructan - 12.5|Dietary Supplement: Fructan -- 5 gramshttps://ClinicalTrials.gov/show/NCT00988403

* Görseller ve İçerik tekif hakkına sahip olabilir